Peterson Wealth Services Acquires 509 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Peterson Wealth Services boosted its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY) by 5.1% in the 4th quarter, Holdings Channel.com reports. The firm owned 10,507 shares of the company’s stock after purchasing an additional 509 shares during the quarter. Peterson Wealth Services’ holdings in HealthEquity were worth $1,008,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently added to or reduced their stakes in the business. Raymond James Trust N.A. raised its position in shares of HealthEquity by 4.8% during the third quarter. Raymond James Trust N.A. now owns 2,905 shares of the company’s stock valued at $238,000 after buying an additional 132 shares during the last quarter. UMB Bank n.a. raised its holdings in HealthEquity by 65.6% in the 4th quarter. UMB Bank n.a. now owns 414 shares of the company’s stock valued at $40,000 after acquiring an additional 164 shares in the last quarter. Truist Financial Corp lifted its position in shares of HealthEquity by 7.0% in the 2nd quarter. Truist Financial Corp now owns 2,864 shares of the company’s stock worth $247,000 after acquiring an additional 188 shares during the period. Elk River Wealth Management LLC grew its holdings in shares of HealthEquity by 0.3% during the 3rd quarter. Elk River Wealth Management LLC now owns 66,181 shares of the company’s stock worth $5,417,000 after purchasing an additional 217 shares in the last quarter. Finally, Nicolet Advisory Services LLC increased its position in shares of HealthEquity by 5.8% during the third quarter. Nicolet Advisory Services LLC now owns 4,218 shares of the company’s stock valued at $330,000 after purchasing an additional 233 shares during the period. Institutional investors own 99.55% of the company’s stock.

Analyst Ratings Changes

HQY has been the subject of several research reports. BTIG Research raised their target price on HealthEquity from $110.00 to $130.00 and gave the stock a “buy” rating in a research report on Thursday, November 14th. Mizuho started coverage on shares of HealthEquity in a research report on Wednesday, December 4th. They set an “outperform” rating and a $126.00 target price on the stock. Bank of America upped their target price on shares of HealthEquity from $100.00 to $120.00 and gave the company a “buy” rating in a research note on Wednesday, November 13th. The Goldman Sachs Group started coverage on HealthEquity in a report on Friday, November 15th. They set a “neutral” rating and a $108.00 price objective on the stock. Finally, Royal Bank of Canada increased their target price on HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a report on Tuesday, December 10th. One research analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $110.71.

Insider Transactions at HealthEquity

In related news, Director Stuart B. Parker sold 25,000 shares of the business’s stock in a transaction that occurred on Thursday, December 12th. The shares were sold at an average price of $96.72, for a total transaction of $2,418,000.00. Following the completion of the sale, the director now directly owns 19,061 shares of the company’s stock, valued at $1,843,579.92. The trade was a 56.74 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director Robert W. Selander sold 8,250 shares of HealthEquity stock in a transaction on Monday, December 9th. The stock was sold at an average price of $101.56, for a total transaction of $837,870.00. Following the sale, the director now directly owns 66,469 shares of the company’s stock, valued at $6,750,591.64. This represents a 11.04 % decrease in their position. The disclosure for this sale can be found here. 2.20% of the stock is currently owned by corporate insiders.

HealthEquity Stock Performance

Shares of NASDAQ:HQY opened at $112.15 on Tuesday. The business has a fifty day moving average of $101.18 and a 200-day moving average of $89.98. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. HealthEquity, Inc. has a twelve month low of $65.01 and a twelve month high of $113.61. The firm has a market cap of $9.72 billion, a PE ratio of 102.89, a price-to-earnings-growth ratio of 1.61 and a beta of 0.55.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings data on Monday, December 9th. The company reported $0.59 earnings per share for the quarter, missing the consensus estimate of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same quarter last year, the firm posted $0.40 earnings per share. On average, equities research analysts predict that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.